These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1902498)

  • 21. Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.
    Güldütuna S; Langenbeck U; Bock KW; Sieg A; Leuschner U
    Dig Dis Sci; 1995 Jan; 40(1):28-32. PubMed ID: 7821116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness to phenobarbital in an adult with Crigler-Najjar disease associated with neurological involvement and skin hyperextensibility.
    Persico M; Romano M; Muraca M; Gentile S
    Hepatology; 1991 Feb; 13(2):213-5. PubMed ID: 1899849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Crigler-Najjar syndrome].
    Torres M; Bruguera M
    Gastroenterol Hepatol; 2005 Dec; 28(10):637-40. PubMed ID: 16373016
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful photo-and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II.
    Holstein A; Plaschke A; Lohse P; Egberts EH
    Scand J Gastroenterol; 2005 Sep; 40(9):1124-6. PubMed ID: 16211719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial unconjugated hyperbilirubinemia syndromes.
    Reichen J
    Semin Liver Dis; 1983 Feb; 3(1):24-35. PubMed ID: 6836332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome in maternal Crigler-Najjar syndrome type II: a case report and systematic review of the literature.
    Passuello V; Puhl AG; Wirth S; Steiner E; Skala C; Koelbl H; Kohlschmidt N
    Fetal Diagn Ther; 2009; 26(3):121-6. PubMed ID: 19752526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phenobarbital in Crigler-Najjar syndrome type 1: A therapeutic option].
    Rubio Gómez I; López González MF; Ibáñez Alcalde MM; Cañabate Reche F
    An Pediatr (Barc); 2016 Aug; 85(2):115-116. PubMed ID: 27134052
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnosis and management of Crigler-Najjar syndrome.
    Jansen PL
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S89-94. PubMed ID: 10603107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Prolonged survival in the Crigler-Najjar syndrome: ultrastructural and dietary studies.
    Gollan JL; Huang SN; Billing BH; Sherlock S
    Gut; 1974 Oct; 15(10):838. PubMed ID: 4434967
    [No Abstract]   [Full Text] [Related]  

  • 30. Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.
    Lee WS; McKiernan PJ; Beath SV; Preece MA; Baty D; Kelly DA; Burchell B; Clarke DJ
    Arch Dis Child; 2001 Jul; 85(1):38-42. PubMed ID: 11420196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
    Hafkamp AM; Nelisse-Haak R; Sinaasappel M; Oude Elferink RP; Verkade HJ
    Pediatr Res; 2007 Dec; 62(6):725-30. PubMed ID: 17957158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Fibrosis Associated With Crigler-Najjar Syndrome in a Compound Heterozygote: A Case Report.
    Fata CR; Gillis LA; Pacheco MC
    Pediatr Dev Pathol; 2017; 20(6):522-525. PubMed ID: 28590786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II.
    Gordon ER; Shaffer EA; Sass-Kortsak A
    Gastroenterology; 1976 May; 70(5 PT.1):761-5. PubMed ID: 1261771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte transplantation.
    Lake JR
    N Engl J Med; 1998 May; 338(20):1463-5. PubMed ID: 9580657
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Crigler-Najjar type II with small-dose phenobarbital.
    Younossi ZM; Foroozan P
    Dig Dis Sci; 1995 Mar; 40(3):575. PubMed ID: 7895547
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurophysiological follow-up of two siblings with Crigler-Najjar syndrome type I and review of literature.
    Bayram E; Öztürk Y; Hız S; Topçu Y; Kılıç M; Zeytunlu M
    Turk J Pediatr; 2013; 55(3):349-53. PubMed ID: 24217087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II].
    Drenth JP; Peters WH; Jansen JB
    Ned Tijdschr Geneeskd; 2002 Aug; 146(32):1488-90. PubMed ID: 12198827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes.
    Costa E; Vieira E; Martins M; Saraiva J; Cancela E; Costa M; Bauerle R; Freitas T; Carvalho JR; Santos-Silva E; Barbot J; Dos Santos R
    Blood Cells Mol Dis; 2006; 36(1):91-7. PubMed ID: 16269258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new frame-shifting mutation of UGT1A1 gene causes type I Crigler-Najjar syndrome.
    Wang J; Fang LJ; Li L; Wang JS; Chen C
    Chin Med J (Engl); 2011 Dec; 124(23):4109-11. PubMed ID: 22340355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis.
    Ciotti M; Obaray R; Martín MG; Owens IS
    Am J Med Genet; 1997 Jan; 68(2):173-8. PubMed ID: 9028453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.